Related Experiment Videos
TGF-beta signalling from cell membrane to nucleus through SMAD proteins
C H Heldin1, K Miyazono, P ten Dijke
1Ludwig Institute for Cancer Research, Biomedical Centre, Uppsala, Sweden.
Nature
|December 11, 1997
Summary
The SMAD proteins mediate transforming growth factor-beta (TGF-beta) signaling from the cell surface to the nucleus. Inhibitory SMADs have been discovered that can block this crucial TGF-beta pathway activation.
Area of Science:
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-beta (TGF-beta) signaling is critical for cellular functions.
- Understanding TGF-beta signal transduction pathways is essential for deciphering cellular responses.
Purpose of the Study:
- To elucidate the molecular mechanisms of TGF-beta signal transduction.
- To identify key proteins involved in transmitting TGF-beta signals to the nucleus.
Main Methods:
- Identification and characterization of the SMAD protein family.
- Analysis of protein phosphorylation by serine/threonine kinase receptors.
- Investigation of protein-protein interactions and nuclear translocation.
Main Results:
- The SMAD family of proteins acts as signal transducers for TGF-beta.
- Pathway-restricted SMADs are phosphorylated by TGF-beta receptors.
- SMADs oligomerize with Smad4 and translocate to the nucleus to regulate transcription.
- Inhibitory SMADs function to block pathway-restricted SMAD activation.
Conclusions:
- The SMAD pathway is central to TGF-beta signal transduction.
- SMAD proteins mediate TGF-beta's effects on gene transcription.
- Inhibitory SMADs provide a regulatory mechanism within the TGF-beta pathway.